Estradiol Transdermal Patches

Women's Health

Generic For Alora, Vivelle-DOT

starting at $59.99

Estradiol (estrogen) is a female hormone used to help alleviate symptoms of menopause, including vaginal dryness, burning, and painful intercourse. Estradiol transdermal patches are FDA-approved to treat vulvar and vaginal atrophy associated with menopause. Vaginal atrophy (atrophic vaginitis) is thinning, drying and inflammation of the vaginal walls that may occur when your body has less estrogen.

Used to help reduce symptoms of menopause, such as vaginal dryness, burning, and painful intercourse

Must be 60 years of age or younger or within 10 years of menopause

Maintenance dosing ranges from 0.025mg/24hr to 0.1mg/24hr

Apply to lower abdomen or buttons, do not apply to breasts. Apply to clean, dry, intact skin

Suitable for patients already taking this medication

HSA/FSA Eligible

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Estradiol Transdermal Patches

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and understand that a medical provider will rely on the truthfulness of your statements when determining whether a prescription is warranted and appropriate.

I agree that I:

am 18 years or older
have not had a hypersensitivity reaction to estradiol or any component of the formulation
am using this treatment as intended for menopause
do not have abnormal genital bleeding
do not have migraine headaches with aura
do not have a current or history of blood clots, including venous thromboembolism (VTE) or deep vein thrombosis (DVT), or arterial thromboembolic disease such as stroke or heart attack
do not have a history of breast cancer or estrogen dependent tumor
do not have hepatic (liver) impairment or disease
do not have a blood disorder, including deficiencies in protein C, protein S, antithrombin, or other blood clotting diseases
understand this medication may interact with medications being metabolized similarly, including phenobarbital, phenytoin, rifampin, and St. John’s Wort
am not pregnant or breastfeeding
understand this medication may increase the risk of endometrial cancer and/or exacerbate endometriosis, and increase the risk of ovarian cancer and invasive breast cancer
understand this medication may increase risk of DVT, pulmonary embolism, stroke, or myocardial infarction in postmenopausal women
understand this medication may increase the risk of pancreatitis, cholelithiasis, and cholecystitis
understand this medication may increase the risk of dementia
understand this medication may increase the risk of blood clots in the retina (retinal vascular thrombosis) and will discontinue if experiencing migraine, loss of vision or other vision changes
understand this medication may worsen other disease states or conditions (e.g. asthma, cardiovascular disease, diabetes mellitus, epilepsy, and migraine)
understanding smoking cigarettes while taking this therapy will significantly increase risk of blood clot
understand transdermal patches may contain conducting material such as aluminum and must be removed prior to MRI
understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Medication Description

Estradiol transdermal patches deliver systemic estrogen therapy through the skin to help manage moderate to severe symptoms of menopause, such as vaginal dryness, burning, and painful intercourse. These patches are FDA-approved to treat vulvar and vaginal atrophy (atrophic vaginitis), a condition resulting from decreased estrogen levels that causes thinning and inflammation of the vaginal tissues.

As a transdermal delivery method, these patches provide continuous estrogen exposure with steady absorption and may offer an alternative to oral hormone therapy. Estradiol patches are generally recommended for women within 10 years of menopause or under the age of 60.

How to Use:

Apply to clean, dry, intact skin on the lower abdomen or buttocks

Do not apply to the breasts or areas of irritated skin

Rotate application sites with each patch change to avoid skin irritation

Typical dosing ranges from 0.025 mg/24hr to 0.1 mg/24hr

Frequency of patch change varies by brand—follow provider instructions

Warnings:

Use the lowest effective dose for the shortest duration consistent with treatment goals as directed by your provider

May increase the risk of blood clots, stroke, or certain cancers—routine monitoring is advised

Do not use if pregnant or if you have a history of estrogen-sensitive cancers, unexplained vaginal bleeding, or liver dysfunction
Estradiol Transdermal Patches Side Effects

Estradiol transdermal patches side effects may include breast pain, constipation, anxiety, bloating, vaginal discharge, confusion, chest pain, increased urination or headache.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.